Cannabis Actually Reduced Sleep Time and Suppressed REM in People With Insomnia

Pilot randomized controlled trial, N=20 patients with DSM-5 diagnosed insomnia disorder (16 female, mean age 46.1). Single oral dose: 10 mg THC + 200 mg CBD vs. placebo. 256-channel high-density EEG sleep recordings. Outcomes: sleep architecture (total sleep time, REM, NREM stages), spectral power analysis, next-day alertness (objective and subjective).

Cannabis is one of the most commonly cited self-medications for sleep problems. This study — using the gold standard of sleep measurement — found it actually made things worse by objective measures. The REM suppression is particularly significant because REM sleep is critical for emotional regulation, memory consolidation, and cognitive function. People may feel cannabis helps sleep because of subjective sedation, while their actual sleep quality deteriorates.

This directly challenges the cannabis-for-sleep narrative and connects to the foundational sleep research in this database. The withdrawal sleep studies (RTHC-00037, RTHC-00012) documented sleep disruption when cannabis stops — this study shows sleep is also disrupted when cannabis is actively used. The PTSD abstinence study (RTHC-00274) found symptom improvement with quitting, which may partly reflect sleep improvement. The pattern across these studies suggests cannabis creates a cycle: it provides subjective sedation but impairs objective sleep quality, and stopping it causes temporary rebound insomnia that convinces users they need it to sleep.

Small sample (N=20) with a single dose — does not capture effects of repeated use or tolerance development. The 10 mg THC / 200 mg CBD ratio is specific to this formulation; other ratios may produce different effects. Mostly female sample (80%) limits generalizability to men. Single-night measurement may not reflect typical sleep patterns. Acute effects may differ from chronic use effects.